1298 related articles for article (PubMed ID: 15332282)
1. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
Mangano AM; Remesar M; del Pozo A; Sen L
J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
[TBL] [Abstract][Full Text] [Related]
2. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina.
Berini CA; Eirin ME; Pando MA; Biglione MM
J Med Virol; 2007 Jan; 79(1):69-73. PubMed ID: 17133550
[TBL] [Abstract][Full Text] [Related]
3. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I.
Yao K; Hisada M; Maloney E; Yamano Y; Hanchard B; Wilks R; Rios M; Jacobson S
J Infect Dis; 2006 Feb; 193(3):427-37. PubMed ID: 16388491
[TBL] [Abstract][Full Text] [Related]
4. Molecular evidence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from São Paulo, Brazil.
Costa JM; Segurado AC
J Clin Virol; 2009 Mar; 44(3):185-9. PubMed ID: 19188090
[TBL] [Abstract][Full Text] [Related]
5. Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean.
Rouet F; Meertens L; Courouble G; Herrmann-Storck C; Pabingui R; Chancerel B; Abid A; Strobel M; Mauclere P; Gessain A
J Clin Microbiol; 2001 Apr; 39(4):1247-53. PubMed ID: 11283036
[TBL] [Abstract][Full Text] [Related]
6. Serological patterns and temporal trends of HTLV-1/2 infection in high-risk populations attending Public Health Units in São Paulo, Brazil.
Jacob F; Santos-Fortuna E; Azevedo RS; Caterino-de-Araujo A
J Clin Virol; 2008 Jun; 42(2):149-55. PubMed ID: 18346935
[TBL] [Abstract][Full Text] [Related]
7. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
Kwon SY; Lim AH; Park JY; Han SH; Cho NS
J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
[TBL] [Abstract][Full Text] [Related]
9. Use of a generic polymerase chain reaction assay detecting human T-lymphotropic virus (HTLV) types I, II and divergent simian strains in the evaluation of individuals with indeterminate HTLV serology.
Vandamme AM; Van Laethem K; Liu HF; Van Brussel M; Delaporte E; de Castro Costa CM; Fleischer C; Taylor G; Bertazzoni U; Desmyter J; Goubau P
J Med Virol; 1997 May; 52(1):1-7. PubMed ID: 9131450
[TBL] [Abstract][Full Text] [Related]
10. Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses.
Pancake BA; Zucker-Franklin D; Marmor M; Legler PM
Proc Assoc Am Physicians; 1996 Nov; 108(6):444-8. PubMed ID: 8956367
[TBL] [Abstract][Full Text] [Related]
11. Lack of evidence for human T cell lymphotrophic virus type I or II infection in patients with systemic lupus erythematosus or rheumatoid arthritis.
Bailer RT; Lazo A; Harisdangkul V; Ehrlich GD; Gray LS; Whisler RL; Blakeslee JR
J Rheumatol; 1994 Dec; 21(12):2217-24. PubMed ID: 7535355
[TBL] [Abstract][Full Text] [Related]
12. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.
Varma M; Rudolph DL; Knuchel M; Switzer WM; Hadlock KG; Velligan M; Chan L; Foung SK; Lal RB
J Clin Microbiol; 1995 Dec; 33(12):3239-44. PubMed ID: 8586709
[TBL] [Abstract][Full Text] [Related]
13. Neither molecular diversity of the envelope, immunosuppression status, nor proviral load causes indeterminate HTLV western blot profiles in samples from human T-cell lymphotropic virus type 2 (HTLV-2)-infected individuals.
Olah I; Fukumori LM; Smid J; de Oliveira AC; Duarte AJ; Casseb J
J Med Virol; 2010 May; 82(5):837-42. PubMed ID: 20336719
[TBL] [Abstract][Full Text] [Related]
14. Long-term serological follow-up of blood donors with an HTLV-indeterminate western blot: antibody profile of seroconverters and individuals with false reactions.
Martins ML; Santos AC; Namen-Lopes MS; Barbosa-Stancioli EF; Utsch DG; Carneiro-Proietti AB
J Med Virol; 2010 Oct; 82(10):1746-53. PubMed ID: 20827773
[TBL] [Abstract][Full Text] [Related]
15. HTLV-I/II seroindeterminate Western blot reactivity in a cohort of patients with neurological disease.
Soldan SS; Graf MD; Waziri A; Flerlage AN; Robinson SM; Kawanishi T; Leist TP; Lehky TJ; Levin MC; Jacobson S
J Infect Dis; 1999 Sep; 180(3):685-94. PubMed ID: 10438355
[TBL] [Abstract][Full Text] [Related]
16. The best algorithm to confirm the diagnosis of HTLV-1 and HTLV-2 in at-risk individuals from São Paulo, Brazil.
Costa EA; Magri MC; Caterino-de-Araujo A
J Virol Methods; 2011 May; 173(2):280-6. PubMed ID: 21349293
[TBL] [Abstract][Full Text] [Related]
17. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
Kumar H; Gupta PK
Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
[TBL] [Abstract][Full Text] [Related]
18. Detection of HTLV-I and -II in Scottish blood donor samples and archive donations.
Davidson F; Lycett C; Jarvis LM; Kerr D; Lumley S; Petrik J; Dow BC
Vox Sang; 2006 Oct; 91(3):231-6. PubMed ID: 16958835
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of human T cell lymphotropic virus type 1 and 2 (HTLV-1/2) seroindeterminate blood donors from Northeast Iran: evidence of proviral tax, env, and gag sequences.
Zanjani DS; Shahabi M; Talaei N; Afzalaghaee M; Tehranian F; Bazargani R
AIDS Res Hum Retroviruses; 2011 Feb; 27(2):131-5. PubMed ID: 20929385
[TBL] [Abstract][Full Text] [Related]
20. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
